Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9413
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang Huang, Ruei- | - |
dc.contributor.author | -Hsiang Chiu, Chun | - |
dc.contributor.author | -Sheng Shang, Hung | - |
dc.contributor.author | -Lih Perng, Cherng | - |
dc.contributor.author | Ta Chiang, Tsung- | - |
dc.contributor.author | -Chou Tsai, Chun | - |
dc.date.accessioned | 2024-12-20T02:19:58Z | - |
dc.date.available | 2024-12-20T02:19:58Z | - |
dc.date.issued | 2022-12-01 | - |
dc.identifier.issn | 1684-1182 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/9413 | - |
dc.description.abstract | Abstract Background/Purpose: Clinical characteristics of patients in the first community outbreak of coronavirus disease 2019 (COVID-19) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 in Taiwan have not been characterized. Methods: SARS-CoV-2 positive specimens from inpatients between May 7 and June 15 in 2021were screen for SARS-CoV-2 B.1.1.7 lineage by VirSNiP assay. Clinical characteristics were reviewed and compared with those from Feb 1 to April 30, 2020 and from Jan 1 to March 31, 2022. Results: One hundred forty-one inpatients from May 7 to June 15, 2021 infected with SARS-CoV-2 B.1.1.7 lineage were included. The major presenting symptoms were fever (88.7%) and cough (59.6%). Incidence of relevant complications including pulmonary embolism, simultaneous infections with bacteria, virus, and fungi were 0.7%, 12.8%, 13.5%, and 2.1%, respectively. Old age, high Charlson comorbidity index, short of breath, and initial critical illness were independently associated with 28-day mortality (all p < 0.05). In comparison to COVID-19 inpatients from Feb 1 to April 30, 2020, patients from the outbreak by SARS-CoV-2 B.1.1.7 lineage were older, more severe in disease condition, higher mortality but less obvious initial presenting symptoms. After implementation of nationwide vaccination campaign in the next half year of 2021, COVID-19inpatients from Jan 1 to March 31 in 2022 indicated less severe diseases than those infected with SARS-CoV-2 B.1.1.7 lineage. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Taiwan LLC | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | ; SARS-COV-2; | en_US |
dc.subject | B.1.1.7; B.1.1.529; | en_US |
dc.subject | Taiwan; | en_US |
dc.subject | Characteristics | en_US |
dc.title | Clinical characteristics analysis of COVID-19 patients from the first significant community outbreak by SARS-CoV-2 variant B.1.1.7 in Taiwan as experienced from a single northern medical center | en_US |
dc.type | Article | en_US |
Appears in Collections: | VOL 55 NO 6 Part 1 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1036-1043.pdf | 551.9 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.